Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends
XTalks
AUGUST 2, 2023
This is largely due to failed trials as a prophylaxis resulting in the European Committee for Medical Products (CHMP) recommending against the approval of Lagevrio. percent increase since 2021, predominantly due to Botox sales for therapeutic uses. Botox was first approved by the FDA in 1989 for blepharospasms and strabismus in adults.
98 
Let's personalize your content